Stephen Neeleman Sells 30,000 Shares of HealthEquity Inc. (HQY) Stock
HealthEquity Inc. (NASDAQ:HQY) insider Stephen Neeleman sold 30,000 shares of HealthEquity stock in a transaction on Thursday, October 13th. The shares were sold at an average price of $36.19, for a total value of $1,085,700.00. Following the completion of the transaction, the insider now owns 30,000 shares in the company, valued at approximately $1,085,700. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Stephen Neeleman also recently made the following trade(s):
- On Tuesday, September 13th, Stephen Neeleman sold 30,000 shares of HealthEquity stock. The shares were sold at an average price of $33.22, for a total value of $996,600.00.
- On Tuesday, August 23rd, Stephen Neeleman sold 9,898 shares of HealthEquity stock. The shares were sold at an average price of $30.28, for a total value of $299,711.44.
- On Thursday, August 18th, Stephen Neeleman sold 102 shares of HealthEquity stock. The shares were sold at an average price of $30.00, for a total value of $3,060.00.
Shares of HealthEquity Inc. (NASDAQ:HQY) opened at 36.40 on Wednesday. The stock’s 50 day moving average price is $35.86 and its 200-day moving average price is $29.73. The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of 93.33 and a beta of 1.62. HealthEquity Inc. has a 12 month low of $15.80 and a 12 month high of $38.80.
HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.03. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The firm had revenue of $44.20 million for the quarter. During the same quarter last year, the firm posted $0.08 EPS. The business’s quarterly revenue was up 44.9% on a year-over-year basis. Equities analysts forecast that HealthEquity Inc. will post $0.51 earnings per share for the current fiscal year.
Hedge funds have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares during the period. PineBridge Investments L.P. boosted its stake in shares of HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the period. Teacher Retirement System of Texas boosted its stake in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the period. Denver Investment Advisors LLC acquired a new stake in shares of HealthEquity during the second quarter worth approximately $203,000. Finally, Mason Street Advisors LLC acquired a new stake in shares of HealthEquity during the second quarter worth approximately $210,000. Hedge funds and other institutional investors own 90.54% of the company’s stock.
HQY has been the topic of a number of research analyst reports. Raymond James Financial Inc. lifted their target price on HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a report on Monday, September 12th. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthEquity in a report on Wednesday, June 22nd. Barrington Research lifted their target price on HealthEquity from $34.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, September 8th. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, September 9th. Finally, Robert W. Baird raised their price objective on HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Wednesday, September 7th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $36.00.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.